Bibliografía del artículo
1. World Health Organization. Division of Health Promotion, Education and Communication. Promoción de la salud: glosario. Ginebra: Organización Mundial de la Salud, 1998. Disponible en: http://apps.who.int/iris/handle/10665/67246.
2. Falcón M, Luna, A. Alfabetización en salud: concepto y dimensiones. Proyecto europeo de alfabetización en salud. Comunicación y Salud 2(2):91-98, 2012.
3. Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 155(2):97-107, 2011.
4. Sørensen K, Pelikan JM, Röthlin, y col. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health 25(6):1053-1058, 2015.
5. Cho YI, Lee SY, Arozullah AM, Crittenden KS. Effects of health literacy on health status and health service utilization amongst the elderly. Soc Sci Med 66(8):1809-16, 2008.
6. Davis TC, Wolf MS. Health Literacy: Implications for Family Medicine. Fam Med 36(8):595-8, 2004.
7. Gazmararian JA, Williams MV, Peel J, Baker DW. Health literacy and knowledge of chronic disease. Patient Educ Couns 51(3):267-75, 2003.
8. Parker RM, Ratzan SC, Lurie N. Health Literacy: A policy challenge for advancing high-quality health care. Health Aff (Millwood) 22(4):147-53, 2003.
9. Lozano ML, Marín F, Roldán V. Fármacos antitrombóticos en el ámbito extrahospitalario. Medicine: Programa de Formación Médica Continuada Acreditado. España: Doyma; 10(22):1493-1501, 2008.
10. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167(13):1414-1419, 2007.
11. Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res 133(4):550-554, 2014.
12. Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother 37:34-9, 2003.
13. Hasan SS, Shamala R, Syed IA y col. Factors affecting warfarin-related knowledge and INR control of patients attending physician-and pharmacist-managed anticoagulation clinics. J Pharm Pract 24(5):485-493, 2011.
14. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother 39:632-6, 2005.
15. de Felipe Medina, R. Nivel de conocimientos de los pacientes anticoagulados en un centro de salud; relación con el control terapéutico. Aten Primaria 32(2):101-105, 2003.
16. Nybo MS, Skov J. Patient knowledge of anticoagulant treatment does not correlate with treatment quality. Public Health 141:17-22, 2016.
17. Shrestha S, Sapkota B, Kumpakha A, Acharya U, Sharma R. Evaluation of patients knowledge on warfarin in outpatient pharmacy of a tertiary care cardiac center. BMC Res Notes 8(1):429, 2015.
18. Desteghe L, Engelhard L, Raymaekers Z, y col. Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire. Int J Cardiol 223:906-914, 2016.
19. Moran SM, Fitzgerald N, Pope M, Madden M, Vaughan CJ. Warfarin anticoagulation: a survey of patients' knowledge of their treatment. Ir J Med Sci 180(4):819-822, 2011.
20. McCabe PJ, Schad S, Hampton A, Holland DE. Knowledge and self-management behaviors of patients with recently detected atrial fibrillation. Heart Lung 37(2):79-90, 2008.
21. Rewiuk K, Bednarz S, Faryan P, Grodzicki T. Knowledge of antithrombotic prophylaxis among patients with atrial fibrillation. Cardiol J 14(1):44-9, 2007.
22. Rahmani P, Guzman C, Kezouh A, Blostein M, Kahn SR. Association between patient knowledge of anticoagulation, INR control, and warfarin-related adverse events. J Pharm Technol 32(4):150-9, 2016.
23. Baker JW, Pierce KL, Ryals CA. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a veterans affairs medical center. J Manag Care Pharm 17:133-42, 2011.
24. Van Damme S, Van Deyk K, Budts W, Verhamme P, Moons P. Patient knowledge of and adherence to oral anticoagulation therapy after mechanical heart-valve replacement for congenital or acquired valve defects. Heart Lung 40:139-46, 2011.
25. Pernod G, Labarère J, Yver J, Satger B, Allenet B, Berremili T, y col. EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study. J Gen Intern Med 23(9):1441-6, 2008.
26. Fang MC, Machtinger EL,Wang F, Schillinger D. Health literacy and anticoagulationrelated outcomes among patients taking warfarin. J Gen Intern Med 21:841-6, 2006.
27. Oramasionwu CU, Bailey SC, Duffey KE, y col. The association of health literacy with time in therapeutic range for patients on warfarin therapy. J Health Commun 19(sup2):19-28, 2014.
28. Collins S, Barber A, Sahm LJ. Pharmacist's counseling improves patient knowledge regarding warfarin, irrespective of health literacy level. Pharmacy 2(1):114-123, 2014.
29. Diug B, Evans S, Lowthian J, y col. The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy. Stroke 42(10):2866-2871, 2011.
30. Sørensen K, Van den Broucke S, Fullam J, y col. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health 12(1):1, 2012.
31. Levin-Zamir D, Baron-Epel OB, Cohen V, Elhayany A. The association of health literacy with health behavior, socioeconomic indicators, and self-assessed health from a national adult survey in Israel. J Health Commun 21(sup2):61-68, 2016.
32. Madrid, AH, Potpara TS, Dagres N, y col. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace 18(3):463-467, 2016.
33. Ruiz Moral R, Peralta Munguía L, Pérula de Torres LA, y col. Opiniones y percepciones de los pacientes sobre su participación en la toma de decisiones en las consultas de medicina de familia. Aten Primaria 44(1):5-10, 2012.
34. Brown TM, Sin K, Walker D, Pladevall-Vila M, Sander S, Mordin M. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Manag Care Pharm 18(5):351-62, 2012.
35. Nasser S, Mullan J, Bajorek B. Challenges of older patients knowledge about warfarin therapy. J Prim Care Community Health 3(1):65-74, 2012.
36. Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM. The caregiver role in thromboprophylaxis management in atrial fibrillation: A literature review. Eur J Cardiovasc Nurs 14(2):98-107, 2015.
37. Wofford JL, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res 8(1):1, 2008.